# Long-term Antipsychotic Pediatric Safety Trial

> **NCT03522168** · — · COMPLETED · sponsor: **Duke University** · enrollment: 509 (actual)

## Conditions studied

- Weight, Body

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT03522168
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2023-11-21
- **Final completion:** 2023-11-21
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03522168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03522168, "Long-term Antipsychotic Pediatric Safety Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03522168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*